Massachusetts Financial Services Co. MA Sells 48,241 Shares of Revvity Inc. $RVTY

Massachusetts Financial Services Co. MA reduced its holdings in shares of Revvity Inc. (NYSE:RVTY – Free Report) by 4.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,097,539 shares of the company’s stock after selling 48,241 shares during the quarter. Massachusetts Financial Services Co. MA’s holdings in Revvity were worth $106,187,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in RVTY. AQR Capital Management LLC boosted its stake in shares of Revvity by 5.2% during the 1st quarter. AQR Capital Management LLC now owns 8,449 shares of the company’s stock worth $883,000 after acquiring an additional 420 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Revvity by 6.7% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company’s stock worth $1,246,000 after acquiring an additional 744 shares during the period. Millennium Management LLC boosted its stake in shares of Revvity by 102.0% during the 1st quarter. Millennium Management LLC now owns 69,401 shares of the company’s stock worth $7,343,000 after acquiring an additional 35,048 shares during the period. Goldman Sachs Group Inc. boosted its stake in shares of Revvity by 45.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company’s stock worth $64,232,000 after acquiring an additional 189,871 shares during the period. Finally, Focus Partners Wealth boosted its stake in shares of Revvity by 13.0% during the 1st quarter. Focus Partners Wealth now owns 7,028 shares of the company’s stock worth $744,000 after acquiring an additional 811 shares during the period. 86.65% of the stock is currently owned by institutional investors.

Revvity Price Performance

Shares of NYSE RVTY opened at $92.54 on Tuesday. The stock has a market capitalization of $10.35 billion, a PE ratio of 44.49, a P/E/G ratio of 1.91 and a beta of 1.13. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.68 and a quick ratio of 1.40. The business has a fifty day moving average price of $92.93 and a two-hundred day moving average price of $96.86. Revvity Inc. has a fifty-two week low of $81.36 and a fifty-two week high of $118.30.

Revvity (NYSE:RVTY – Get Free Report) last announced its quarterly earnings data on Monday, February 2nd. The company reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.15. The firm had revenue of $772.06 million during the quarter, compared to analysts’ expectations of $759.81 million. Revvity had a return on equity of 7.92% and a net margin of 8.45%.The company’s quarterly revenue was up 5.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.42 EPS. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. As a group, equities analysts predict that Revvity Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 8th. Shareholders of record on Friday, April 17th will be issued a $0.07 dividend. The ex-dividend date of this dividend is Friday, April 17th. This represents a $0.28 annualized dividend and a yield of 0.3%. Revvity’s payout ratio is currently 13.46%.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Wells Fargo & Company lifted their target price on Revvity from $107.00 to $110.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 3rd. Barclays boosted their price target on Revvity from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Tuesday, February 3rd. Weiss Ratings lowered Revvity from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, March 18th. Bank of America downgraded Revvity from a “buy” rating to a “neutral” rating and set a $110.00 target price for the company. in a report on Monday, December 15th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Revvity from $105.00 to $96.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 31st. Five analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Revvity presently has an average rating of “Hold” and an average target price of $112.92.

Check Out Our Latest Research Report on Revvity

About Revvity

(Free Report)

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

Read More

• Five stocks we like better than Revvity

Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity Inc. (NYSE:RVTY – Free Report).